Morten Asser Karsdal

Jan 6, 2025 | nature.com | Martin Pehrsson |Anne-Christine Bay-Jensen |Morten Asser Karsdal |Bent Deleuran |Tue W. Kragstrup |Satoshi KUBO | +2 more

AbstractUnderstanding how inflammatory cytokines influence profibrogenic wound healing responses in fibroblasts is important for understanding the pathogenesis of fibrosis. TNF-α and IL-13 are key cytokines in Th1 and Th2 immune responses, respectively, while TGF-β1 is the principal pro-fibrotic mediator.

Feb 20, 2024 | bpspubs.onlinelibrary.wiley.com | Simone Anna Melander |Anna Larsen |Morten Asser Karsdal |Kim Henriksen

DATA AVAILABILITY STATEMENT The data that support the findings of this manuscript are available from the corresponding author upon reasonable request.

Dec 8, 2023 | mdpi.com | Annika Hummersgaard Hansen |Joachim Høg Mortensen |Sarah Rank Rønnow |Morten Asser Karsdal

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Aug 19, 2023 | onlinelibrary.wiley.com | Jeppe Thorlacius-Ussing |Nordic Bioscience A |Søren Risom Kristensen |Morten Asser Karsdal

INTRODUCTION Small cell lung cancer (SCLC) is a rapidly progressive form of cancer with a poor prognosis that accounts for approximately 15% of all lung cancer cases.1 Despite recent advances, such as promising outcomes from immunotherapy,2 treatment options for SCLC are still restricted and primarily involve chemotherapy drugs such as platinum agents (cisplatin or carboplatin) and topoisomerase inhibitors (etoposide or irinotecan).